Literature DB >> 22825090

Metabolic syndrome as a risk factor for hypertension after preeclampsia.

Julia J Spaan1, Simone J S Sep, Veronica Lopes van Balen, Marc E A Spaanderman, Louis L H Peeters.   

Abstract

OBJECTIVE: To identify metabolic and obstetric risk factors associated with hypertension after preeclampsia.
METHODS: We analyzed demographic and clinical data from a postpartum screening (blood pressure, microalbuminuria and fasting plasma levels of glucose, insulin, and lipid profile) from 683 primiparous women with a history of preeclampsia. We excluded women with pre-existing hypertension, kidney disease, or diabetes mellitus. In the group of women who were normotensive at postpartum screening, we evaluated the risk of developing chronic hypertension in the years after screening using questionnaires.
RESULTS: Hypertension at postpartum screening (n=107, 17% of all cases) was related to obesity (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.1-3.2), elevated fasting levels of insulin (OR 1.7, 95% CI 1.0-2.9), low-density lipoprotein (OR 1.6, 95% CI 1.1-2.6), microalbuminuria (OR 2.3, 95%-CI 1.3-4.0), family history of hypertension (OR 1.8, 95% CI 1.1-2.8), and delivery before 34 weeks of gestation (OR 2.5, 95% CI 1.6-4.0). We identified 27 cases of hypertension within 2,095 person-years during a median 6-year follow-up in the group of women normotensive at postpartum screening. The hazard rate for the development of hypertension was 2.9 (95% CI 1.2-7.5) and 8.1 (95% CI 2.8-22.9), respectively, when two and three or more components of the metabolic syndrome were present; 3.7 (95% CI 1.4-10.0) for family history of hypertension; and 4.3 (95% CI 1.6-11.5) for recurrence of a hypertensive disorder in pregnancy.
CONCLUSION: Several metabolic and obstetric risk factors related to hypertension postpartum in the short term and predisposed to the subsequent development of chronic hypertension after preeclampsia in initially normotensive women. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Year:  2012        PMID: 22825090     DOI: 10.1097/AOG.0b013e31825f21ff

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

1.  Lipoprotein-associated phospholipase A2 is associated with postpartum hypertension in women with history of preeclampsia.

Authors:  Yuheng Zhou; Jianmin Niu; Dongmei Duan; Qiong Lei; Jiying Wen; Xiaohong Lin; Lijuan Lv; Longding Chen
Journal:  Heart Vessels       Date:  2014-04-23       Impact factor: 2.037

2.  Long-Term Risk to Develop Hypertension in Women With Former Preeclampsia: A Longitudinal Pilot Study.

Authors:  Chahinda Ghossein-Doha; Marc Spaanderman; Sander M J van Kuijk; Abraham A Kroon; Tammo Delhaas; Louis Peeters
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

3.  Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study.

Authors:  Carmen A H Severens-Rijvers; Salwan Al-Nasiry; Chahinda Ghossein-Doha; Sara Marzano; Hugo Ten Cate; Bjorn Winkens; Marc A E Spaanderman; Louis L H Peeters
Journal:  Gynecol Obstet Invest       Date:  2016-09-20       Impact factor: 2.031

4.  Clinical study on the association between pregnancy-induced hypertension and insulin resistance.

Authors:  Zhifang Chen; Weiling Liu; Xiaoqin Sun; Lingling Zhu
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

5.  Formerly eclamptic women have lower nonpregnant blood pressure compared with formerly pre-eclamptic women: a retrospective cohort study.

Authors:  M P Schreurs; M J Cipolla; S Al-Nasiry; L L H Peeters; M E A Spaanderman
Journal:  BJOG       Date:  2015-03-09       Impact factor: 6.531

6.  Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis.

Authors:  L Brouwers; A J van der Meiden-van Roest; C Savelkoul; T E Vogelvang; A T Lely; A Franx; B B van Rijn
Journal:  BJOG       Date:  2018-08-10       Impact factor: 6.531

Review 7.  Hypertensive Disorders of Pregnancy and Future Cardiovascular Health.

Authors:  Karen Melchiorre; Basky Thilaganathan; Veronica Giorgione; Anna Ridder; Alessia Memmo; Asma Khalil
Journal:  Front Cardiovasc Med       Date:  2020-04-15

8.  Diabetes mellitus and drug abuse during pregnancy and the risk for orofacial clefts and related abnormalities.

Authors:  Ivy Kiemle Trindade-Suedam; Lília Maria von Kostrisch; Luiz André Freire Pimenta; Carlos Antônio Negrato; Solange Braga Franzolin; Alceu Sergio Trindade
Journal:  Rev Lat Am Enfermagem       Date:  2016-08-08

9.  The Risk Factors That Predict Chronic Hypertension After Delivery in Women With a History of Hypertensive Disorders of Pregnancy.

Authors:  Ji-Won Hwang; Sung-Ji Park; Soo-Young Oh; Sung-A Chang; Sang-Chol Lee; Seung Woo Park; Duk-Kyung Kim
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.